Holen Sie sich die Stockscreener-App
183.97
1.14%
1.965
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$182.01
Offen:
$181.67
24-Stunden-Volumen:
686.00K
Relative Volume:
0.34
Marktkapitalisierung:
$37.32B
Einnahmen:
$11.99B
Nettoeinkommen (Verlust:
$1.09B
KGV:
34.23
EPS:
5.3752
Netto-Cashflow:
$1.85B
1W Leistung:
-2.04%
1M Leistung:
-10.72%
6M Leistung:
+8.36%
1J Leistung:
+10.46%
1-Tages-Spanne:
$181.64
$184.37
1-Wochen-Bereich:
$180.18
$190.09
52-Wochen-Spanne:
$150.04
$239.48
Hershey Company Stock (HSY) Company Profile
Firmenname
Hershey Company
Sektor
Branche
Telefon
(717) 534-4200
Adresse
19 EAST CHOCOLATE AVENUE, HERSHEY, PA
Compare HSY vs MDLZ, TR, SOWG, RMCF
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HSY
Hershey Company
|
183.99 | 36.92B | 11.99B | 1.09B | 1.85B | 5.3752 |
MDLZ
Mondelez International Inc
|
60.88 | 78.79B | 39.30B | 2.62B | 2.58B | 2.017 |
TR
Tootsie Roll Industries Inc
|
42.50 | 3.14B | 732.52M | 99.98M | 96.35M | 1.3397 |
SOWG
Sow Good Inc
|
2.73 | 13.33M | 0 | 0 | 0 | 0.00 |
RMCF
Rocky Mountain Chocolate Factory Inc
|
2.66 | 22.21M | 29.64M | -4.04M | -2.65M | -0.5237 |
Hershey Company Stock (HSY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-21 | Bestätigt | Stifel | Hold |
| 2026-04-14 | Eingeleitet | BTIG Research | Neutral |
| 2026-02-12 | Bestätigt | Stephens | Overweight |
| 2026-02-06 | Bestätigt | Evercore ISI | In-line |
| 2026-02-02 | Bestätigt | DA Davidson | Neutral |
| 2026-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2026-01-05 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2025-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-11 | Bestätigt | Stifel | Hold |
| 2025-12-04 | Fortgesetzt | Jefferies | Hold |
| 2025-10-31 | Hochstufung | Piper Sandler | Underweight → Neutral |
| 2025-09-16 | Hochstufung | Goldman | Sell → Buy |
| 2025-09-15 | Hochstufung | BNP Paribas Exane | Neutral → Outperform |
| 2025-08-20 | Fortgesetzt | JP Morgan | Neutral |
| 2025-07-31 | Bestätigt | Bernstein | Mkt Perform |
| 2025-07-31 | Bestätigt | BofA Securities | Neutral |
| 2025-07-31 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2025-05-28 | Bestätigt | Mizuho | Neutral |
| 2025-05-02 | Bestätigt | Bernstein | Mkt Perform |
| 2025-03-24 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2025-02-07 | Hochstufung | Citigroup | Sell → Neutral |
| 2025-01-31 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2025-01-23 | Bestätigt | Deutsche Bank | Hold |
| 2024-12-23 | Bestätigt | Mizuho | Neutral |
| 2024-12-12 | Fortgesetzt | BofA Securities | Neutral |
| 2024-12-12 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-10-22 | Eingeleitet | Redburn Atlantic | Sell |
| 2024-10-07 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-10-07 | Herabstufung | UBS | Buy → Neutral |
| 2024-09-26 | Herabstufung | Jefferies | Hold → Underperform |
| 2024-08-27 | Herabstufung | Citigroup | Neutral → Sell |
| 2024-08-14 | Herabstufung | Argus | Buy → Hold |
| 2024-08-12 | Eingeleitet | Goldman | Sell |
| 2024-07-17 | Bestätigt | Citigroup | Neutral |
| 2024-04-19 | Herabstufung | Edward Jones | Buy → Hold |
| 2024-03-26 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2024-02-12 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-02-01 | Eingeleitet | Citigroup | Neutral |
| 2024-01-29 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2023-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-08 | Eingeleitet | DA Davidson | Neutral |
| 2023-11-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-11-21 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-27 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-10-13 | Eingeleitet | Stephens | Overweight |
| 2023-09-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-13 | Eingeleitet | TD Cowen | Outperform |
| 2023-08-11 | Bestätigt | Argus | Buy |
| 2023-07-19 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2023-04-28 | Bestätigt | Barclays | Equal Weight |
| 2023-04-28 | Bestätigt | BofA Securities | Buy |
| 2023-04-28 | Bestätigt | Deutsche Bank | Hold |
| 2023-04-28 | Bestätigt | Evercore ISI | In-line |
| 2023-04-28 | Bestätigt | Jefferies | Hold |
| 2023-04-28 | Bestätigt | Stifel | Hold |
| 2023-04-28 | Bestätigt | UBS | Buy |
| 2023-04-28 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-04-14 | Fortgesetzt | Stifel | Hold |
| 2023-03-29 | Eingeleitet | Wells Fargo | Underweight |
| 2023-03-24 | Bestätigt | Mizuho | Neutral |
| 2023-01-06 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-01-03 | Eingeleitet | Wells Fargo | Underweight |
| 2022-12-08 | Hochstufung | UBS | Neutral → Buy |
| 2022-11-15 | Eingeleitet | Exane BNP Paribas | Neutral |
| 2022-09-14 | Eingeleitet | Cowen | Market Perform |
| 2022-03-30 | Eingeleitet | UBS | Neutral |
| 2022-02-07 | Hochstufung | Argus | Hold → Buy |
| 2022-02-07 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-02-04 | Bestätigt | BMO Capital Markets | Outperform |
| 2022-02-04 | Bestätigt | BofA Securities | Buy |
| 2022-02-04 | Bestätigt | Credit Suisse | Outperform |
| 2022-02-04 | Bestätigt | Deutsche Bank | Hold |
| 2022-02-04 | Bestätigt | Evercore ISI | Outperform |
| 2022-02-04 | Bestätigt | Goldman | Buy |
| 2022-02-04 | Bestätigt | Mizuho | Neutral |
| 2022-02-04 | Bestätigt | Stifel | Hold |
| 2022-01-27 | Eingeleitet | Mizuho | Neutral |
| 2021-10-29 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-10-29 | Bestätigt | Credit Suisse | Outperform |
| 2021-10-29 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-29 | Bestätigt | Piper Sandler | Overweight |
| 2021-10-29 | Bestätigt | RBC Capital Mkts | Outperform |
| 2021-09-21 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-04-15 | Hochstufung | Goldman | Neutral → Buy |
| 2021-03-17 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-02-08 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-01-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-10-19 | Eingeleitet | Citigroup | Buy |
| 2020-09-29 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2020-07-24 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-04-24 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-04-23 | Herabstufung | CFRA | Hold → Sell |
| 2020-04-21 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2020-03-25 | Hochstufung | Edward Jones | Hold → Buy |
| 2020-03-25 | Hochstufung | Piper Sandler | Underweight → Overweight |
| 2020-03-18 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-01-23 | Eingeleitet | Jefferies | Hold |
| 2020-01-22 | Eingeleitet | Jefferies | Hold |
| 2019-12-20 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-12-12 | Fortgesetzt | Deutsche Bank | Hold |
| 2019-10-17 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2019-07-26 | Bestätigt | BofA/Merrill | Buy |
| 2019-07-22 | Hochstufung | UBS | Sell → Neutral |
| 2019-07-17 | Hochstufung | Goldman | Sell → Neutral |
| 2019-06-20 | Herabstufung | Piper Jaffray | Neutral → Underweight |
| 2019-06-19 | Bestätigt | BofA/Merrill | Buy |
| 2019-06-12 | Eingeleitet | Evercore ISI | In-line |
Alle ansehen
Hershey Company Aktie (HSY) Neueste Nachrichten
Hershey reports sales boost linked to "Ozempic breath" - WGAL
Hershey Trust (NYSE: HSY) trims stake, holds 54.6M Class B - Stock Titan
DA Davidson Issues Pessimistic Forecast for Hershey (NYSE:HSY) Stock Price - MarketBeat
How Marketers Can Get Clean Incrementality Measurements in a Messy World - ADWEEK
Strs Ohio Has $17.14 Million Stock Position in Hershey Company (The) $HSY - MarketBeat
Baypointe Partners LLC Cuts Stake in Hershey Company (The) $HSY - MarketBeat
Hershey sales of mints and gum sees uptick from ‘Ozempic breath’ - NewsNation
The Hershey Company Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - simplywall.st
Hershey, PA Pennsylvania HERSHEY'S CHOCOLATE FACTORY Aerial View 4X6 Postcard - aviglianonews.it
In 1893, Milton Hershey Saw a Chocolate-Making Machine at the Chicago World’s Fair: That Encounter Establi - The Economic Times
The Hershey Company Just Beat EPS By 8.1%: Here's What Analysts Think Will Happen Next - Yahoo Finance
Citizens Financial Group Inc. RI Raises Stake in Hershey Company (The) $HSY - MarketBeat
Hotels, Sustainability & Coffee: This Week’s Top Stories - Food Digital
Ozempic breath is boosting Hershey's sales of mints and gum - MSN
Hershey Co. stock underperforms Friday when compared to competitors - MarketWatch
Hershey Claims GLP-1 Use Is Causing ‘Strong Demand’ for Its Gum and Mints - People.com
Video Hershey CEO says the chocolate giant has seen a jump in sales of mints and gumABC News - ABC News - Breaking News, Latest News and Videos
The Hershey Co (HSY) Q1 2026 Earnings Call Highlights: Strong Ea - GuruFocus
Hershey sees spike in sales due to GLP-1 weight loss drugs, company says - 6abc Philadelphia
Hershey Exceeds Earnings Expectations as Health Conscious Snacking Grows - HarianBasis.co
Higher prices help Hershey top first-quarter estimates - Mass Market Retailers
Hershey's CEO Claims Ozempic Breath is Driving Massive Surge in Mint and Gum Sales Across the United States - International Business Times UK
Hershey Beat Q1 2026 Estimates by Nearly 15%. Can the Stock Reach $236 by 2027? - TIKR.com
Bernstein Adjusts Hershey Price Target to $208 From $250 - marketscreener.com
The Hershey Company (NYSE:HSY) Q1 2026 Earnings Call Transcript - Insider Monkey
Hershey ‘laser-focused on fueling core growth,’ CEO says - Bakingbusiness.com
CEO: Hershey ‘feels good about where we’re headed’ - Food Business News
Hershey Earnings Call Highlights Resilient Demand, Margin Turn - TipRanks
"Ozempic breath" is boosting Hershey's sales of mints and gum - CBS News
How The Hershey Company wins in modern media - The Trade Desk
Got ‘Ozempic breath?’ Hershey sees GLP-1 lift for mints, gum - The Detroit News
The Hershey Company Q1 2026 Earnings Call Summary - Yahoo Finance
Hershey Company (The) Plans Quarterly Dividend of $1.45 (NYSE:HSY) - MarketBeat
The Hershey Company (HSY) Q1 2026 Earnings Show Strong Performan - GuruFocus
Hershey reports 10.6% increase in net sales for Q1FY2026 financial results - Milling Middle East & Africa
Hershey CEO on Making Luxury Chocolate Accessible—and Battling Ozempic Breath - WSJ
Hershey Delivers Sweet Beat But Cost Pressures Leave A Bitter Taste - Benzinga
Hershey beats Q1 2026 earnings estimates on price hikes - qz.com
Hershey (HSY) Q1 2026 Earnings Transcript - The Globe and Mail
Hershey tops estimates as GLP‑1 users drive demand for mints, healthier snacks - Reuters
Hershey says GLP-1s are driving higher gum and mint sales - MSN
Hershey: A Bitter Macro Environment Demands A Higher Margin Of Safety (NYSE:HSY) - Seeking Alpha
Hershey Q1 Earnings Top Estimates on Pricing-Led Sales Growth - Yahoo Finance
Hershey's (HSY) Reports Strong Q1 Results with Revenue Surpassin - GuruFocus
Hershey tops quarterly estimates as higher prices, salty snacks demand cushion hit from costs - KFGO
Got ‘Ozempic Breath?’ Hershey Sees GLP-1 Boost for Mints, Gum - Bloomberg.com
Hershey beats Q1 expectations but dips on softer guidance outlook - Yahoo Finance
Hershey bounces back as profits jump 93% - Confectionery News
Hershey shares pressured despite Q1 beat as cost pressures weigh on margins - MSN
Hershey sales up on pricing as “elasticity” eats into volumes - Yahoo Finance
Hershey shares pressured despite Q1 beat as cost pressures weigh on margins (HSY:NYSE) - Seeking Alpha
Finanzdaten der Hershey Company-Aktie (HSY)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.63%
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):